Ibuprofen does not affect levels of tumor necrosis factor α and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria

European Cytokine Network

Volumn 18, Issue 4, 2007, Pages 201-205

  Matsiegui, Pierre Blaise ^a,b   Missinou, Michel A ^a,b   Issifou, Saadou ^a   Necek, Magdalena ^a,c   Mavoungou, Elie ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

falciparum; Fever; Ibuprofen; Malaria; TNF

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR; IBUPROFEN; QUININE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; GABON; HOSPITALIZATION; HUMAN; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ANIMALS; ANTIMALARIALS; CHILD; DOUBLE-BLIND METHOD; GABON; HUMANS; IBUPROFEN; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; PLACEBOS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; QUININE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SULFADOXINE; TUMOR NECROSIS FACTOR-ALPHA;

PLASMODIUM FALCIPARUM;

EID: 37848998833     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2007.0105     Document Type: Article

References (34)

1. Munday S. Review of intermittent preventive treatment for malaria in infants and children. J Paediatr Child Health 2007; 43: 424.
2. Kern P, Hemmer CJ, Damme JV, et al. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989; 87: 139.
3. Kern P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992; 166: 930.
4. Kremsner PG, Winkler S, Brandts C, et al. Predictions of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 1995; 53: 532.
5. Richards AL. Tumor necrosis factor and associated cytokines in the host's response to malaria. Int J Parasitol 1997; 27: 1251.
6. Day NP, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis 1999; 180: 1288.
7. Mordmüller BG, Metzger WG, Juillard P, et al. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 1997; 8: 29.
8. McGuire W, D'Alessandro U, Stephens S, et al. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans R Soc Trop Med Hyg 1998; 92: 50.
9. Akanmori BD, Kurtzhals JA, Goka BQ, et al. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 2000; 11: 113.
10. Gimenez F, Barraud de Lagerie S, et al. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 2003; 60: 1623.
11. Lucas R, Juillard P, Decoster E, et al. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol 1997; 27: 1719.
12. Molyneux ME, Engelmann H, Taylor TE, et al. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 1993; 5: 604.
13. Piguet PF, Kan CD, Vesin C. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab Invest 2002; 82: 1155.
14. Fried M, Muga RO, Misore AO, et al. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998; 160: 2523.
15. Moorman AM, Sullivan AD, Rochford RA, et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999; 180: 1987.
16. Taverne J. Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun 1990; 58: 2923.
17. Engelmann H, Aderka D, Rubinstein M, et al. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264: 11974.
18. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996;7:231.
19. Carpentier I, Coornaert B, Beyaert R. Function and regulation of tumor necrosis factor type 2. Curr Med Chem 2004; 11: 2205.
20. Matsiegui PB, Missinou MA, Necek M, et al. Antipyretic effect of Ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double blind, placebo controlled trial. (Submitted).
21. Wildling E, Winkler S, Kremsner PG, et al. Malaria epidemiology in the province of the Moyen Ogooué, Gabon. Trop Med Parasitol 1995; 46: 77.
22. Sylla EH, Kun JF, Kremsner PG. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans R Soc Trop Med Hyg 2000; 94: 652.
23. Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65: 599.
24. Brandts CH, Ndjavé M, Graninger W, et al. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997; 350: 1776.
25. Renda G, Tacconelli S, Capone ML, et al. Celecoxib, ibuprofen and antiplatelet effect of aspirin in patients with osteoartnritis and ischemic heart disease. Clin Pharmacol Ther 2006; 80: 264.
26. Kern P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992; 166: 930.
27. Molyneux ME, Engelmann H, Taylor TE, et al. Circulating plasma receptors for tumor necrosis factor in Malawian children with severe falciparum malaria. Cytokine 1993; 5: 604.
28. Engelberts I, Stephens S, Francot GJM, et al. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 1991; 338: 515.
29. Lesslauer W, Tabuchi H, Gentz R, et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991; 21: 2883.
30. Ashkenazi A, Marsters SA, Capon DJ, et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 1991; 88: 10535.
31. Van Zee KJ, Kohno T, Fisher E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845.
32. Schleiffenbaum B, Olgiati L, Fehr J. TNF-specific deactivation of granulocytes in vivo a possible mechanism of self protection. Eur J Haematol 1992; 49: 239.
33. Medana IM, Hunt NH, Chaudhri G. Tumor necrosis factor- expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol 1997; 150: 1473.
34. Lell B, Sovric M, Schmid D, Luckner D, et al. Effect of antipyretic drugs in children with malaria. Clin Infect Dis 2001; 32: 838.